The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
Mismatch repair–deficient (dMMR) tumors can be found in 10 to 15% of patients with nonmetastatic colon cancer. In these patients, the efficacy of chemotherapy is limited. The use of neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results